Efficacy and Safety of Renal Function on Edoxaban Versus Warfarin for Atrial Fibrillation: A Systematic Review and Meta-Analysis

Background: Edoxaban is a novel oral anticoagulant which may decrease the risk of stroke and systemic embolism in patients suffering from atrial fibrillation (AF). However, the decreased efficacy of edoxaban versus warfarin for the avoidance of stroke and systemic embolism in AF with creatinine clea...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yapeng, Li, Li, Wei, Zhanlan, Lu, Shan, Liu, Wenxue, Zhang, Janghui, Feng, Junbo, Wang, Dongjin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861612/
https://www.ncbi.nlm.nih.gov/pubmed/36662497
http://dx.doi.org/10.3390/medicines10010013

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9861612/
https://www.ncbi.nlm.nih.gov/pubmed/36662497
http://dx.doi.org/10.3390/medicines10010013

Ejemplares similares